Permeation enhancing polymers in oral delivery of hydrophilic macromolecules:: thiomer/GSH systems

被引:215
作者
Bernkop-Schnürch, A [1 ]
Kast, CE [1 ]
Guggi, D [1 ]
机构
[1] Univ Vienna, Ctr Pharm, Inst Pharmaceut Technol & Biopharmaceut, A-1090 Vienna, Austria
关键词
thiomer; permeation enhancement; glutathione; oral drug delivery; calcitonin; insulin; low molecular weight heparin;
D O I
10.1016/j.jconrel.2003.05.001
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Thiolated polymers (=thiomers) in combination with reduced glutathione (GSH) were shown to improve the uptake of hydrophilic macromolecules from the GI tract. The mechanism responsible for this permeation enhancing effect seems to be based on the thiol groups of the polymer. These groups inhibit protein tyrosine phosphatase, being involved in the closing process of tight junctions, via a GSH-mediated mechanism. The strong permeation enhancing effect of various thiomer/GSH systems such as poly(acrylic acid) - cysteine/GSH or chitosan-4-thio-butylamidine (chitosan-TBA)/GSH could be shown via permeation studies on freshly excised intestinal mucosa in Ussing-type chambers. Furthermore, the efficacy of the system was also shown in vivo. By utilizing poly(acrylic acid)- cysteine/GSH as carrier matrix, an absolute oral bioavailability for low molecular weight heparin of 19.9+/-9.3% and a pharmacological efficacy-calculated on the basis of the areas under the reduction in serum glucose levels of the oral formulation versus subcutaneous (s.c.) injection-for orally given insulin of 7% could be achieved. The incorporation of salmon calcitonin in chitosan-TBA/GSH led on the other hand to a pharmacological efficacy based on the areas under the reduction in plasma calcium levels of the oral thiomer formulation versus intravenous (i.v.) injection of 1.3%. Because of this high efficacy (i), the possibility to combine thiomer/GSH systems with additional low molecular weight permeation enhancers acting in other ways (ii) and minimal toxicological risks as these polymers are not absorbed from the GI tract (iii), thiolated polymers represent a promising novel tool for the oral administration of hydrophilic macromolecules. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:95 / 103
页数:9
相关论文
共 45 条
[1]
Aungst BJ, 2000, J PHARM SCI, V89, P429, DOI 10.1002/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO
[2]
2-J
[3]
Enhancement of the intestinal absorption of peptides and nonpeptides [J].
Aungst, BJ ;
Saitoh, H ;
Burcham, DL ;
Huang, SM ;
Mousa, SA ;
Hussain, MA .
JOURNAL OF CONTROLLED RELEASE, 1996, 41 (1-2) :19-31
[4]
Effects of polyacrylic polymers on the degradation of insulin and peptide drugs by chymotrypsin and trypsin [J].
Bai, JPF ;
Chang, LL ;
Guo, JH .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (01) :17-21
[5]
SUBCHRONIC ORAL TOXICITY STUDY WITH REGULAR AND ENZYMATICALLY DEPOLYMERIZED SODIUM CARBOXYMETHYLCELLULOSE IN RATS [J].
BAR, A ;
TIL, HP ;
TIMONEN, M .
FOOD AND CHEMICAL TOXICOLOGY, 1995, 33 (11) :909-917
[6]
Regulation of PTP1B via glutathionylation of the active site cysteine 215 [J].
Barrett, WC ;
DeGnore, JP ;
König, S ;
Fales, HM ;
Keng, YF ;
Zhang, ZY ;
Yim, MB ;
Chock, PB .
BIOCHEMISTRY, 1999, 38 (20) :6699-6705
[7]
Bemkop-Schnurch A, 1999, SCI PHARM, V67, P196
[8]
Polymers with thiol groups:: A new generation of mucoadhesive polymers? [J].
Bernkop-Schnürch, A ;
Schwarz, V ;
Steininger, S .
PHARMACEUTICAL RESEARCH, 1999, 16 (06) :876-881
[9]
Synthesis and in vitro evaluation of chitosan-EDTA-protease-inhibitor conjugates which might be useful in oral delivery of peptides and proteins [J].
Bernkop-Schnürch, A ;
Scerbe-Saiko, A .
PHARMACEUTICAL RESEARCH, 1998, 15 (02) :263-269
[10]
Chitosan and its derivatives:: potential excipients for peroral peptide delivery systems [J].
Bernkop-Schnürch, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 194 (01) :1-13